(WO/1996/022082) VALACICLOVIR TABLETS CONTAINING COLLOIDAL SILICON DIOXIDE
- Biblio. Data
- Description
- Claims
- National Phase
- Notices
- Documents
| Latest bibliographic data on file with the International Bureau
| |||||||||||||||||||
| |||||||||||||||||||
| IPC: | A61K 9/20 (2006.01) | ||||||||||||||||||
| Applicants: | THE WELLCOME FOUNDATION LIMITED [GB/GB]; Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB) (All Except US). CARTER, Barry, Howard [US/US]; (US) (US Only). TILLMAN, Lloyd, Gary [US/US]; (US) (US Only). | ||||||||||||||||||
| Inventors: | CARTER, Barry, Howard; (US). TILLMAN, Lloyd, Gary; (US). | ||||||||||||||||||
| Agent: | McMUNN, Watson, P.; W.H. Beck, Greener & Co., 7 Stone Buildings, Lincoln's Inn, London WC2A 3SZ (GB). | ||||||||||||||||||
| Priority Data: |
| ||||||||||||||||||
| Title: | VALACICLOVIR TABLETS CONTAINING COLLOIDAL SILICON DIOXIDE | ||||||||||||||||||
| Abstract: | A tablet comprising of at least 50 % w/w valaciclovir, and 0.05 to 3 % w/w colloidal silicon dioxide is provided which has excellent hardness and friability properties while still maintaining good lubrication of the tablet granules. | ||||||||||||||||||
| Designated States: |
AL, AM, AT, AU, AZ, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IS, JP, KE, KG, KP, KR, KZ, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN. African Regional Intellectual Property Org. (ARIPO) (KE, LS, MW, SD, SZ, UG) Eurasian Patent Organization (EAPO) (AZ, BY, KG, KZ, RU, TJ, TM) European Patent Office (EPO) (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE) African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG). | ||||||||||||||||||
| Publication Language: | English (EN) |
| Filing Language: | English (EN) |
